AIBT AIBOTICS, INC.

AIBT financial statements, revenue, balance sheet, cash flow, and SEC filings

CIK: 1763329 Exchange: OTC SIC: 2833 (Medicinal Chemicals & Botanical Products) Latest filing: 10-Q filed Aug 19, 2026 Data checked: Oct 21, 2026
Showing 3 of 8 annual and 0 of 32 quarterly periods. Full history available with a free account or via API.

▼ Company Profile

Filer Category
Non-accelerated filer<br>Smaller reporting company
Entity Type
Operating
Public Float
$1.37M (Jun 2025)
Industry (SIC)
2833 Medicinal Chemicals & Botanical Products
Incorporated
NV
Fiscal Year End
December (1231)
Phone
208-677-2020
EIN
870645794
Headquarters
HEYBURN, ID, 83336
Public Float History
Market value of shares held by public investors, reported in annual DEI filings.
Former Names: Mycotopia Therapies, Inc. (2021–2024) · 20/20 Global, Inc. (2019–2021)

▼ Key Metrics (TTM)

As of Jun 30, 2026
Financials
Revenue
$0
Net Income
$-2.09M
Total Assets
$549.59K
Total Equity
$-4.60M
Total Debt
-
Free Cash Flow
-
Ratios
Return on Equity
45.5%
Return on Assets
-380.9%
Current Ratio
0.05x

▼ FY 2025 Summary Analysis

Annual report ending Dec 31, 2025

Overview and Growth

In fiscal 2025, AIBOTICS, INC. recorded $2.18K of revenue, net loss of $2.22M, and an operating cash outflow of $458.24K. Revenue of $2.18K sets the scale for evaluating how effectively sales translated into profit and cash during the year. Total assets stood at $874.67K, showing the scale of resources supporting revenue, earnings, liquidity, and financing. Asset turnover was 0.0x, relating the company’s annual revenue directly to the total assets reported at the period end.

Profitability

After reported cost of revenue, the company retained $2.18K as gross profit before recognizing operating expenses and other items. Gross margin was 100.0%, so that share of each revenue unit remained after the cost of revenue reported for the period. The company recorded an operating loss of $1.84M after the reported operating expense base. The bottom-line result was a net loss of $2.22M after operating, financing, tax, and other recognized items. The company reported negative EBITDA of $1.84M, adding a pre-interest, tax, depreciation, and amortization view of the operating shortfall. The pretax result was a loss of $2.22M, establishing the deficit before tax effects. The company recognized $0.00 of income tax for the period, completing the transition from pretax income to net income. Relative to total assets, the net loss represented 253.3%. Compared with a $1.85M net loss in fiscal 2024, the current loss increased to $2.22M.

Liquidity and Capital Structure

The company held $874.67K of assets against $4.83M of liabilities and -$3.96M of equity, revealing how the asset base was financed. With total equity at -$3.96M, the company carried a negative book-capital position, increasing its reliance on liabilities and future earnings. The near-term balance sheet paired $270.11K of current assets with $4.79M of current liabilities at the reporting date. At 0.06x, current liabilities exceeded current assets and placed pressure on the company’s near-term liquidity position. Cash and equivalents totaled $255.94K, identifying the most liquid reported component available within the broader current-asset balance. Cash and equivalents represented 5.3% of current liabilities, showing the portion of near-term obligations matched by reported cash alone. The equity-to-assets relationship was -452.8%, placing book capital against the total resource base. Liabilities represented 552.8% of total assets, quantifying the liability-funded share of the company’s resource base. The cash-to-assets relationship was 29.3%, comparing reported cash and equivalents with the full positive asset balance. Total assets were 40.0% lower than fiscal 2024 assets of $1.46M, measuring the company’s own balance-sheet change. Compared with $185.10K in fiscal 2024, the current cash balance moved 38.3% and finished higher.

Cash Flow and Earnings Quality

The company reported an operating cash outflow of $458.24K, rather than cash generation from operations. Compared with a $259.04K operating cash outflow in fiscal 2024, the current outflow increased to $458.24K.
Based on the annual report for the fiscal year ending Dec 31, 2025. Analysis generated .
Sources and calculation details

Reported values are preserved. Derived values use the listed inputs; unavailable inputs remain blank.

Field-level sources for this historical record are unavailable until it is rebuilt from SEC facts.

Annual financial statements for AIBOTICS, INC.
Metric FY2025 📄 FY2024 📄 FY2023 📄
Income Statement
REVENUE
Revenue $2.18K $0 -
Gross Profit $2.18K $0 -
OPERATING EXPENSES
SG&A Expense $1.85M $1.63M $616.72K
Operating Income $-1.84M $-1.63M $-616.72K
NON-OPERATING INCOME / EXPENSE
Interest Expense $226.90K $213.46K $564.62K
Other Income/Expense $-371.08K $-213.46K $-564.62K
Pretax Income $-2.22M $-1.85M $-1.18M
Income Tax $0 $0 $0
Net Income $-2.22M $-1.85M $-1.18M
PER SHARE & SUPPLEMENTAL
EBITDA $-1.84M $-1.63M $-615.73K
Depreciation & Amortization $0 $498 $998
Balance Sheet
ASSETS
Cash & Equivalents $255.94K $185.10K $279.13K
Other Current Assets $14.17K $0 -
Current Assets $270.11K $185.10K $279.13K
PP&E (Net) - $0 $498
Noncurrent Assets $604.57K $1.27M $1.94M
Total Assets $874.67K $1.46M $2.22M
LIABILITIES
Accounts Payable $532.30K $283.34K $341.36K
Current Liabilities $4.79M $4.85M $4.25M
Noncurrent Liabilities $41.04K $0 $0
Total Liabilities $4.83M $4.85M $4.25M
EQUITY
Common Stock $486.90K $39.99K $14.90K
Additional Paid-in Capital $8.58M $7.37M $6.92M
Retained Earnings $-13.03M $-10.81M $-8.96M
Total Equity $-3.96M $-3.39M $-2.03M
Temporary Equity - - $0
Total Liabilities & Equity $874.67K $1.46M $2.22M
SUPPLEMENTAL
Shares Outstanding 486.90M 39.99M 14.90M
Check: A − (L + E + Temp. Equity) - - -
Cash Flow Statement
Cash from Operations $-458.24K $-259.04K $-106.77K
Capital Expenditures - - -
Cash from Investing $0 $0 $0
Cash from Financing $529.08K $165.00K $0
Free Cash Flow - - -
Beginning Cash (CFS) $185.10K $279.13K $385.90K
Net Change in Cash $70.84K $-94.04K $-106.77K
Effect of FX on Cash - - -
Calculated Ending Cash $255.94K $185.10K $279.13K
Cash per BS $255.94K $185.10K $279.13K
Cash scope difference (CFS − BS) - - -
Cash per CFS $255.94K $185.10K $279.13K

Create a free account to see full history, quarterly data, charts, CSV downloads, and API access.

Create Free Account Log In
🔒

Quarterly data and charts require a free account

Get access to 8 quarters of data, interactive charts, CSV downloads, and API access.

▼ Frequently Asked Questions

What is AIBOTICS, INC.'s annual revenue?

AIBOTICS, INC. reported $0 in revenue for trailing twelve months (ending June 2026). Revenue figures are sourced from the company's annual SEC EDGAR filing.

Is AIBOTICS, INC. profitable?

No. AIBOTICS, INC. reported $-2.09M in net income for trailing twelve months. Profitability data is based on the company's most recent annual report filed with the SEC.